Regenerex Pharma (RGPX) Leases (2023 - 2025)
Regenerex Pharma (RGPX) reported Leases of $527235.0 for Q3 2025, down 15.73% year-over-year from $625679.0 in Q3 2024, and down 6.91% on a QoQ basis from $566353.0 in Q2 2025.
Regenerex Pharma (RGPX) has 3 years of Leases data on file, last reported at $527235.0 in Q3 2025.
- Quarterly Leases fell 15.73% year-over-year to $527235.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $527235.0 (down 15.73% YoY) and the FY2025 annual result came in at $604262.0, down 20.11% from the prior year.
- Leases eased to $527235.0 in Q3 2025 per RGPX's latest filing, from $566353.0 in the prior quarter.
- Across five years, Leases topped out at $940348.0 in Q2 2023 and bottomed at $527235.0 in Q3 2025.
- The 3-year median for Leases is $680763.5 (2024), against an average of $711962.6.
- The widest annual swing landed in 2024, when Leases tumbled 30.76%; it then slipped 15.73% in 2025.
- Tracing RGPX's Leases over 3 years: stood at $834293.0 in 2023, then slipped by 23.16% to $641075.0 in 2024, then declined by 17.76% to $527235.0 in 2025.
- Per Business Quant, the three latest RGPX Leases figures stand at $527235.0 (Q3 2025), $566353.0 (Q2 2025), and $604262.0 (Q1 2025).
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 527,235.00 |
| Jun 30, 2025 | 566,353.00 |
| Mar 31, 2025 | 604,262.00 |
| Dec 31, 2024 | 641,075.00 |
| Sep 30, 2024 | 625,679.00 |
| Jun 30, 2024 | 720,452.00 |
| Mar 31, 2024 | 756,343.00 |
| Dec 31, 2023 | 834,293.00 |
| Sep 30, 2023 | 903,586.00 |
| Jun 30, 2023 | 940,348.00 |